Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor.

Winograd-Katz SE, Levitzki A.

Oncogene. 2006 Nov 30;25(56):7381-90. Erratum in: Oncogene. 2007 Feb 1;26(5):788.

PMID:
16785992
2.

Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.

Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M, Prigent SA, Manson MM.

Biochem Pharmacol. 2003 Feb 1;65(3):361-76.

PMID:
12527329
4.

Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.

Cuadrado A, Garcia-Fernandez LF, Gonzalez L, Suarez Y, Losada A, Alcaide V, Martinez T, Fernandez-Sousa JM, Sanchez-Puelles JM, Munoz A.

J Biol Chem. 2003 Jan 3;278(1):241-50.

5.

Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.

Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD.

J Cell Physiol. 2005 Jun;203(3):538-46.

PMID:
15573401
6.

p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression.

Wu W, Silbajoris RA, Whang YE, Graves LM, Bromberg PA, Samet JM.

Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L883-9.

7.

Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases.

LaMarca HL, Dash PR, Vishnuthevan K, Harvey E, Sullivan DE, Morris CA, Whitley GS.

Hum Reprod. 2008 Aug;23(8):1733-41. doi: 10.1093/humrep/den178.

8.

Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor.

Kippenberger S, Loitsch S, Guschel M, Müller J, Knies Y, Kaufmann R, Bernd A.

J Biol Chem. 2005 Jan 28;280(4):3060-7.

9.

Involvement of PI3K/Akt and p38 MAPK in the induction of COX-2 expression by bacterial lipopolysaccharide in murine adrenocortical cells.

Mercau ME, Astort F, Giordanino EF, Martinez Calejman C, Sanchez R, Caldareri L, Repetto EM, Coso OA, Cymeryng CB.

Mol Cell Endocrinol. 2014 Mar 25;384(1-2):43-51. doi: 10.1016/j.mce.2014.01.007.

PMID:
24424443
10.

Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.

Kim SH, Song YC, Kim SH, Jo H, Song YS.

Ann N Y Acad Sci. 2009 Aug;1171:642-8. doi: 10.1111/j.1749-6632.2009.04893.x.

PMID:
19723115
11.

Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.

Okano J, Gaslightwala I, Birnbaum MJ, Rustgi AK, Nakagawa H.

J Biol Chem. 2000 Oct 6;275(40):30934-42.

12.

Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.

Pozuelo-Rubio M, Leslie NR, Murphy J, Mackintosh C.

Cell Biochem Biophys. 2010 Dec;58(3):147-56. doi: 10.1007/s12013-010-9101-4.

13.

Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.

Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.

Int J Oncol. 2006 Jul;29(1):269-78.

PMID:
16773209
14.
16.

UVC radiation induces downregulation of EGF receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells.

Yamauchi T, Adachi S, Yasuda I, Nakashima M, Kawaguchi J, Nishii Y, Yoshioka T, Okano Y, Hirose Y, Kozawa O, Moriwaki H.

Radiat Res. 2011 Nov;176(5):565-74.

PMID:
21692654
17.

Involvement of Akt2/protein kinase B β (PKBβ) in the 8-Cl-cAMP-induced cancer cell growth inhibition.

Choi KY, Ahn YH, Ahn HW, Cho YJ, Hong SH.

J Cell Physiol. 2013 Apr;228(4):890-902. doi: 10.1002/jcp.24240.

PMID:
23018889
18.
19.
20.

Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.

Li B, Chang CM, Yuan M, McKenna WG, Shu HK.

Cancer Res. 2003 Nov 1;63(21):7443-50.

Supplemental Content

Support Center